Ulkur Ersin, Karagoz Huseyin, Celikoz Bahattin, Turan Pinar, Arbak Serap, Yapar Mehmet
Gulhane Military Medical Academy, Haydarpasa Training Hospital, Department of Plastic and Reconstructive Surgery, Istanbul, Turkey.
J Reconstr Microsurg. 2008 Feb;24(2):137-45. doi: 10.1055/s-2008-1076087. Epub 2008 Feb 29.
This study aimed to produce prefabricated nerve graft as effective as autologous nerve graft without donor site morbidity for repairing segmental nerve defects. Thirty rats were used and were separated into three groups. In the first group, vein graft excised from jugular vein was sutured to make a bridge between epineural gaps of tibial and peroneal nerve. In the second group, one-quarter of the nerve diameter was incised after excision of the epineurial sheath, and the vein graft was sutured between epineurial gaps. In the third group, the vein graft was sutured between epineurial gaps, and plasmid including vascular endothelial growth factor (VEGF) gene were injected into muscle next to the nerve. Functional and morphological assessments were performed at the end of the 8 weeks. We prefabricated nerve graft by using autologous vein as a conduit material between two intact nerves and by gene therapy, which increases the VEGF level in the medium.
本研究旨在制备一种预制神经移植物,其效果与自体神经移植物相同,且不存在供体部位并发症,用于修复节段性神经缺损。使用了30只大鼠,并将其分为三组。在第一组中,将从颈静脉切取的静脉移植物进行缝合,以在胫神经和腓总神经的神经外膜间隙之间搭建桥梁。在第二组中,切除神经外膜后切开神经直径的四分之一,然后将静脉移植物缝合于神经外膜间隙之间。在第三组中,将静脉移植物缝合于神经外膜间隙之间,并将包含血管内皮生长因子(VEGF)基因的质粒注射到神经旁的肌肉中。在8周结束时进行功能和形态学评估。我们通过使用自体静脉作为两根完整神经之间的导管材料以及通过基因治疗来预制神经移植物,基因治疗可提高培养基中的VEGF水平。